Kongsberg, November 10, 2020 – Kongsberg Beam Technology has received a Notice of Allowance from the US Patent and Trademark Office. The notice relates to Kongsberg Beam Technology’s first patent family that protects the design of the MAMA-K system, and includes a particle beam guiding system, method, and related radiotherapy system. The company has filed […]
About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.